Cairo – Mubasher: The ordinary general meeting (OGM) of Arab Drug Company approved a cash dividend of EGP 5 per share for fiscal year (FY) 2020/2021, according to a bourse disclosure on Sunday.
The pharmaceutical firm achieved net profits of EGP 102 million in the year ended 30 June, up from EGP 92.8 million a year earlier.
The revenues increased to EGP 537 million in FY20/21, compared to EGP 521.07 million in FY19/20.
